Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats O Guttman, BM Baranovski, R Schuster, Z Kaner, GS Freixo-Lima, ... Clinical & Experimental Immunology 179 (2), 161-172, 2015 | 98 | 2015 |
Characterization of transcriptional regulatory networks that promote and restrict identities and functions of intestinal innate lymphoid cells M Pokrovskii, JA Hall, DE Ochayon, R Yi, NS Chaimowitz, H Seelamneni, ... Immunity 51 (1), 185-197. e6, 2019 | 84 | 2019 |
Persistent immune responses after Ebola virus infection A Sobarzo, DE Ochayon, JJ Lutwama, S Balinandi, O Guttman, RS Marks, ... New England Journal of Medicine 369 (5), 492-493, 2013 | 67 | 2013 |
Acute Phase Protein α1-Antitrypsin Reduces the Bacterial Burden in Mice by Selective Modulation of Innate Cell Responses Z Kaner, DE Ochayon, G Shahaf, BM Baranovski, N Bahar, M Mizrahi, ... The Journal of infectious diseases 211 (9), 1489-1498, 2015 | 62 | 2015 |
α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation A Abecassis, R Schuster, G Shahaf, E Ozeri, R Green, DE Ochayon, ... Cellular & molecular immunology 11 (4), 377-386, 2014 | 54 | 2014 |
IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells DE Ochayon, A Ali, PC Alarcon, D Krishnamurthy, LC Kottyan, ... Journal of leukocyte biology 107 (4), 663-671, 2020 | 37 | 2020 |
Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo DE Ochayon, M Mizrahi, G Shahaf, BM Baranovski, EC Lewis Frontiers in immunology 4, 320, 2013 | 37 | 2013 |
Human α1‐antitrypsin modifies B‐lymphocyte responses during allograft transplantation M Mizrahi, P Cal, M Rosenthal, D Ochayon, G Shahaf, Z Kaner, P Kachker, ... Immunology 140 (3), 362-373, 2013 | 32 | 2013 |
Immune memory to Sudan virus: comparison between two separate disease outbreaks A Sobarzo, Y Eskira, AS Herbert, AI Kuehne, SW Stonier, DE Ochayon, ... Viruses 7 (1), 37-51, 2015 | 24 | 2015 |
The promise and peril of natural killer cell therapies in pulmonary infection S Rajaram, LM Canaday, DE Ochayon, KM Rangel, A Ali, IE Gyurova, ... Immunity 52 (6), 887-889, 2020 | 22 | 2020 |
Tumor microenvironment–derived R-spondins enhance antitumor immunity to suppress tumor growth and sensitize for immune checkpoint blockade therapy Y Tang, Q Xu, L Hu, X Yan, X Feng, A Yokota, W Wang, D Zhan, ... Cancer discovery 11 (12), 3142-3157, 2021 | 16 | 2021 |
Exploration of α1-antitrypsin treatment protocol for islet transplantation: Dosing plan and route of administration BM Baranovski, E Ozeri, G Shahaf, DE Ochayon, R Schuster, N Bahar, ... Journal of Pharmacology and Experimental Therapeutics 359 (3), 482-490, 2016 | 15 | 2016 |
Correspondence of neutralizing humoral immunity and CD4 T cell responses in long recovered Sudan virus survivors A Sobarzo, SW Stonier, AS Herbert, DE Ochayon, AI Kuehne, Y Eskira, ... Viruses 8 (5), 133, 2016 | 10 | 2016 |
The effect of unconventional cytokine combinations on NK-cell responses to viral infection DE Ochayon, SN Waggoner Frontiers in Immunology 12, 645850, 2021 | 9 | 2021 |
Point mutation of a non-elastase-binding site in human α1-antitrypsin alters its anti-inflammatory properties Y Lior, M Zaretsky, DE Ochayon, D Lotysh, BM Baranovski, R Schuster, ... Frontiers in Immunology 9, 759, 2018 | 7 | 2018 |
Dynamic changes in natural killer cell subset frequencies in the absence of cytomegalovirus infection IE Gyurova, H Schlums, H Sucharew, L Ambroggio, DE Ochayon, HT Win, ... Frontiers in Immunology 10, 2728, 2019 | 6 | 2019 |
IL-4 and IL-13 modulate natural killer cell responses under inflammatory conditions MBSNW David E Ohayon, Durga Krishnamurthy The American Association of Immunologists- Washington DC 198 (1), 194.11, 2017 | 5* | 2017 |
Interleukin-33 modulates human natural killer cell responses DE Ohayon, A Ali, PC Alarcon, D Krishnamurthy, AR Osterburg, ... The Journal of Immunology 200 (1_Supplement), 164.21-164.21, 2018 | 4 | 2018 |
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease SD Reighard, D Krishnamurthy, H Cevik, DE Ochayon, A Ali, ... Cytotherapy 23 (1), 37-45, 2021 | 3 | 2021 |
Application of directed evolution and back-to-consensus algorithms to human alpha1-antitrypsin leads to diminished anti-protease activity and augmented anti-inflammatory activities Y Lior, M Jasevitch, DE Ochayon, M Zaretsky, EC Lewis, A Aharoni Cellular Immunology 355, 104135, 2020 | 2 | 2020 |